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S U M M A R Y
Background: Staphylococcus intermedius is a very rare human pathogen. There are only 16 cases in the
literature that have described S. intermedius as a cause of infection in humans. Most of these cases have
been described in association with exposure to animals, mostly dogs. However, this pathogen can cause
infection in healthy individuals even without exposure to animals.
Methods: All previous cases of S. intermedius infection included in our literature reviewwere found using
a PubMed search (1960–November 2009) of the English-language medical literature applying the terms
‘Staphylococcus intermedius’, ‘abscess’, ‘infection’, ‘humans’. The references cited in these articles were
examined to identify additional reports.
Results: We describe the ﬁrst case of skin abscesses caused by S. intermedius in an immunocompetent
patient who used intravenous cocaine after coating his syringes with his saliva. We also summarize the
literature regarding infections caused by S. intermedius in humans.
Conclusions: This case illustrates for the ﬁrst time that S. intermedius can cause skin abscesses in humans
after direct inoculation of this pathogen into the skin and soft tissues. Clinicians should be aware of the
fact that although the vast majority of infections from coagulase-positive Staphylococcus infections are
secondary to Staphylococcus aureus, S. intermedius is also a potential pathogen in humans.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Staphylococcus intermedius is a coagulase-positive Staphylococ-
cus that is a very rare cause of infection in humans, despite being
pathogenic in animals.1 We describe, for the ﬁrst time, a case of
skin abscesses that were caused by S. intermedius in an intravenous
drug user and we summarize the available literature on infections
caused by S. intermedius in humans.
2. Case report
A 43-year-old male with a history of chronic hepatitis C
infection and opioid dependence presented with chills after
developing two skin abscesses in the right forearm two days after
injecting intravenous cocaine. The patient denied any exposure to
animals. He had the habit of licking the syringes prior to injecting
cocaine ‘to prevent clotting’. He was afebrile with a temperature
of 36.5 8C, hemodynamically stable, and he had two abscesses in
the forearm, one 2  3 cm and the other 2  2 cm (Figure 1).* Corresponding author. Tel.: +1 617 789 3000; fax: +1 617 787 0452.
E-mail address: tkelesid@gmail.com (T. Kelesidis).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.02.2249Pertinent laboratory investigations revealed a white blood cell
count of 5.1  109/l with 70% polymorphonuclear cells. The
patient underwent incision and drainage of the two abscesses.
Gram staining of the pus revealed Gram-positive cocci in clusters,
and vancomycin 1 g intravenously every 12 h was administered
empirically. Coagulase-positive staphylococci grew in the culture
of the pus and further testing identiﬁed the organism as S.
intermedius. More speciﬁcally, white glistening microbial colo-
nies were isolated on blood and MacConkey agar. The colonies
were coagulase-, pyrrolidonyl arylamidase-, and o-nitrophenyl-
b-D-galactopyranoside-positive. The isolate was identiﬁed cor-
rectly as S. intermedius after analysis with the ID32 Staph system
using the API database. 16S rRNA gene sequence analysis
conﬁrmed the presence of this rare human pathogen. Sensitivity
testing revealed that the isolate was susceptible to oxacillin,
ampicillin/sulbactam, cefazolin, levoﬂoxacin, clindamycin, doxy-
cycline, gentamicin, trimethoprim–sulfamethoxazole, and van-
comycin. The patient was further treated with 875 mg of oral
amoxicillin–clavulanic acid twice daily for a total of two weeks
with resolution of the abscesses. Unfortunately, cultures of saliva
and nasal/oropharyngeal cultures were not performed in our
case, since the patient was discharged prior to ﬁnal identiﬁcation
of the pathogen.ses. Published by Elsevier Ltd. All rights reserved.
[(Figure_1)TD$FIG]
Figure 1. Two abscesses in the forearm (one 2  3 cm and the other 2  2 cm) that
developed two days after intravenous cocaine use.
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Staphylococcus intermedius is a coagulase-positive Staphylococ-
cus and a zoonotic organism that can be isolated from dogs,
pigeons, minks, cats, horses, foxes, raccoons, goats, and gray
squirrels.1 Talan et al. calculated the prevalence of this microor-
ganism in dogs as 39%.2 Although this bacterium is pathogenic in
animals, it has been identiﬁed very rarely as a cause of infection in
humans. Human carriage of S. intermedius is uncommon (less than
20%), based on culture of saliva and S. intermedius anti-DNAse
antibodies.3–7 Previous isolations of S. intermedius from humans
have been described in either case reports1,8,9 or in the context of
studies on populations with an increased risk of acquiring S.
intermedius infections (veterinarians and patients bitten by
dogs).2,5,8,10 In the latter population, a higher prevalence of this
species may be assumed, since risk factors for acquiring or
harboring S. intermedius are occupational exposure to pets (e.g.,
veterinarians) and bites from certain animals, including
dogs.2,5,8,10 However S. intermedius can also be a pathogen in
humans, as our case indicates. Thus, we summarize the available
scientiﬁc evidence regarding the role of S. intermedius as a
pathogen in humans.
All previous cases included in our literature review were found
using a PubMed search (1960–November 2009) of the English-
language medical literature applying the terms ‘Staphylococcus
intermedius’, ‘abscess’, ‘infection’, ‘humans’. The references cited in
these articles were examined to identify additional reports.
S. intermedius has been described as a human pathogen in 16
cases in the literature.1,8,9,11–18 One case of infectious endocarditis
caused by S. intermedius in a patient with HIV infection was
reported in the Spanish literature and was not included in our
analysis.9 Thus, we summarize the data from 15 cases of
S. intermedius infections in humans (Table 1).1,8,11–18 The most
frequent clinical presentations are wound infections.8,11,12,15 In
1989, Talan et al. described S. intermedius as a human pathogen for
the ﬁrst time in three cases of dog-bite-induced soft tissue
infection, which were treated with penicillin and amoxicillin–
clavulanate. In humans, it is recognized as an invasive zoonotic
pathogen and has been isolated from 18% of canine-inﬂicted
wounds.8 Cellulitis and a malodorous discharge are common,
while regional adenopathy, fever, and lymphangitis occur in only
20% of cases.10 The true incidence of S. intermedius in human
wound infections is probably underestimated, because coagulase-
positive staphylococci are often misclassiﬁed as Staphylococcus
aureus.1
T. Kelesidis, S. Tsiodras / International Journal of Infectious Diseases 14 (2010) e838–e841e840In addition, single cases of endocarditis,9 catheter-related
bacteremia,1 pneumonia,13 ear infection,14 mastoiditis,17 sinusi-
tis,18 nail bed infection,15 and brain abscess16 have been reported.
Because S. intermedius may also possess enterotoxins,19–21 this
species has been considered in addition to S. aureus as the etiologic
agent of staphylococcal food poisoning.20,22,23
S. intermedius infections have been described in both immu-
nosuppressed (3/15 cases, 20%)1,13,15 and immunocompetent
patients (12/15, 80%).8,11,12,14–18 Based on 13 cases with available
data , the average age of patients was 44 years (range 4–78 years),
and 7/12 (58.3%) were males and 5/12 (41.7%) were females .
From 11 cases with available data on antimicrobial suscepti-
bility of human isolates of S. intermedius,1,11–13,15–18 penicillin
resistance was documented in seven cases (63.6%),11–13,15,16,18
methicillin resistance in three cases (27.3%),13,16,18 cefazolin
resistance in three cases (27.3%),13,16,18 resistance to doxycycline
in ﬁve cases (45.5%),1,12,13,15,18 and resistance to clindamycin in
two cases (18.2%).13,16 Resistance to levoﬂoxacin and co-trimox-
azole and intermediate susceptibility to gentamicin have also been
reported in one case.18 While S. intermedius appears to be more
susceptible to penicillin than S. aureus, it may also be resistant to
penicillin. Hoskins et al. found that b-lactamase was produced in
as many as 55% of S. intermedius isolates.24
From 10 cases with available data on treatment,1,11–14,16–18
antibiotics that have been used for the treatment of S. intermedius
infection, based on susceptibility results and site of infection,
include topical antibiotics (polymyxin, neomycin, oﬂoxacin),
penicillin, amoxicillin–clavulanic acid, vancomycin, and linezolid
(Table 1) . The duration of treatment varied from ﬁve days for
wound infections11 to eight weeks in a case of brain abscess.16 Of
cases with data available on outcome, a complete recovery was
observed in nine cases1,11–14,17,18 and partial recovery in one case16
of S. intermedius infection.1,11–14,16–18
Identiﬁcation of S. intermedius is difﬁcult, since S. intermedius
may be misclassiﬁed as S. aureus unless speciﬁc biochemical tests
are done.14 To clearly distinguish between S. intermedius and S.
aureus, differences in biochemical reactions must be used. The API
database is a system that uses speciﬁc biochemical reactions to
differentiate between the various coagulase-positive staphylococci
and is the primarymethod used in routinemedical practice for this
purpose. In a comparison of the two organisms, Talan et al. found
that in contrast to S. aureus isolates, none of the S. intermedius
isolates had a positive acetoin reaction and all S. intermedius
isolates, but no S. aureus isolates, had a positive b-galactosidase
reaction.2 S. intermedius is coagulase-, pyrrolidonyl arylamidase-,
and o-nitrophenyl-b-D-galactopyranoside-positive and hydrolyses
urea.15 It grows well on blood and MacConkey agars incubated
under aerobic conditions at 35 8C.15 Exact molecular identiﬁcation
is performed by 16S rRNA gene sequencing PCR analysis.15 The
very low frequency of coagulase-positive staphylococci other than
S. aureus in human specimens does not justify the efﬁcient but
expensive identiﬁcation of all coagulase-positive staphylococci
using commercially available galleries. However, speciﬁc bio-
chemical tests and PCR of the 16S rDNA gene could be an effective
alternative in detecting S. intermedius in human infections where
zoonosis is suspected.14
We assume that the patient in our case was a healthy carrier of
S. intermedius in his saliva, and as a result of coating the syringes
with saliva prior to injection of cocaine, development of abscesses
secondary to S. intermedius occurred. Only one case of brain
abscess caused by this pathogen has been described in humans.16
This is the ﬁrst case of a skin abscess caused by S. intermedius in
humans. Ways of transmission other than bites have been
described. Clinicians should be aware of the potential risk of the
development of infections from unusual pathogens isolated in
human saliva,7 as we have shown in this case. S. intermedius is acoagulase-positive Staphylococcus that can cause similar infec-
tions to S. aureus, and astute acumen and detailed history are
paramount to diagnose infections caused by this pathogen.
4. Conclusions
In summary, this case illustrates for the ﬁrst time that S.
intermedius can cause skin abscesses in humans after direct
inoculation of the pathogen into the skin and soft tissues. Clinicians
should be aware of the fact that although the vast majority of
infections from coagulase-positive Staphylococcus infections are
secondary to S. aureus, S. intermedius can also be a potential
pathogen in humans. Infections from this pathogen can occur both
in immunocompetent and immunocompromised patients and
thus a detailed history to identify risk factors for this infection (dog
exposure, veterinary occupation, exposure to saliva) is important.
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